October 19, 2022

High-dose insulin infusion in patients with COVID-19

In Research Study by Alexa Driscoll

This case series highlights that these patients can have high mortality rates and additional clinical attention may be warranted. Excursions from the normal care of these patients may be required to gain euglycemia, including, but not limited to, administration of higher insulin concentrations. Based on this review, the purpose of this letter is to draw further attention to the need for further studies evaluating patients positive for COVID-19 requiring ≥100 units/hour of insulin and its impact on COVID-19 treatment outcomes.

Read More

August 24, 2022

Clinical Outcomes Of Euglycemic Diabetic Ketoacidosis (euDKA) Treated With a Computerized Insulin Algorithm: Descriptive Analysis of a Nationwide Cohort

In Research Study by Alexa Driscoll

In this largest descriptive analysis of a nationwide cohort in the United States shows that euDKA can be safely and effectively treated with a computerized algorithm in the hospital, as patients achieved rapid time to target, rapid resolutionofDKA, and a lowmortality rate.

Read More

April 13, 2022

Hypoglycemia Treatment in the Hospital: The 15/15 Rule is Over

In Research Study by Alexa Driscoll

  Hypoglycemia Treatment in the Hospital: The 15/15 Rule is Over Publication SHM Converge 2022 Date April 8, 2022 Authors Jordan Messler, MD, SFHM, FACP | Robby Booth, CPHQ | Emily Ohanuka, BSN, RN Author Affiliations Glytec, Waltham, MA, USA Author Disclosure: All the authors are employees of Glytec Background Hospitals generally have clear protocols, often nursing driven, for management …

Read More

November 22, 2021

Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia

In by Alexa Driscoll

Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia Publication Journal of Diabetes Science and Technology Date June 23, 2021 Authors David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE1,  Jordan Messler, MD, SFHM, FACP2,  Timothy Valk, MD, FACP, FACE3,  Ram Jagannathan, Ph.D.4, Francisco J. Pasquel, MD, MPH4, Guillermo E. Umpierrez, MD, CDE4 Corresponding Author: David C. Klonoff, M.D., FACP, FRCP (Edin), Fellow …

Read More

August 12, 2021

The Power of Inpatient Glucometrics

In by Alexa Driscoll

The Power of Inpatient Glucometrics Presentation Association of Diabetes Care & Education Specialists Annual Conference 2021 Date August 12th, 2021 Authors Jordan Messler, MD, SFHM, FACP, Kerri Doucette, BSN, RN, RDN, CDCES WHY DATA MATTERS Change is hard: data can make it easier Can’t improve what you can’t measure Regulatory measures are coming How Data Overcomes Barriers to Change Allows …

Read More

June 25, 2021

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools

In by Alexa Driscoll

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools Presentation ADA Virtual 81st Scientific Sessions Date June 25, 2021 Authors Bruce Bode, MD, FACE¹, John Clarke, RN, CDCES², Jordan Messler, MD, SFHM, FACP², Robert Booth, CPHQ² AUTHOR AFFILIATIONS ¹Atlanta Diabetes Associates, Atlanta, GA, USA, …

Read More

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA

In by Alexa Driscoll

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA Presentation ADA Virtual 81st Scientific Sessions Date June 25, 2020 Authors Jordan Messler, MD, SFHM, FACP¹, Priyathama Vellanki, MD², Bruce Bode, MD, FACE³, John Clarke RN, CDCES¹, Robert Booth, CPHQ¹ Author Affiliations ¹Glytec, Waltham, MA, USA, ²Emory University School of Medicine, Atlanta, GA, USA, ³Atlanta Diabetes Associates, Atlanta, …

Read More

March 12, 2021

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19

In by Alexa Driscoll

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19 Publication JAMA Network Open Date March 10, 2021 Authors Francisco J. Pasquel, MD, MPH1; Jordan Messler, MD2; Robert Booth, CPHQ2; Beata Kubacka, MSN, AGPCNP-BC, RDN2; April Mumpower, BSHI2; Guillermo Umpierrez, MD1; Joseph Aloi, MD3 Author Affiliations: 1Department of Medicine, Emory University School of Medicine, …

Read More

February 26, 2021

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

In by Alexa Driscoll

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept Publication Diabetes Care Date February 2021 Authors Georgia M. Davis,1 Eileen Faulds,2 Tara Walker,3 Debbie Vigliotti,4 Marina Rabinovich,4 Joi Hester,5 Limin Peng,6 Barbara McLean,7 Patricia Hannon,7 Norma Poindexter,7 Petrena Saunders,7 Citlalli Perez-Guzman,1 Seema S. Tekwani,8 Greg S. Martin,8 …

Read More

June 18, 2020

Reduction of Hypoglycemia Across 180 U.S. Hospitals Using eGlycemic Management System® for IV Insulin Therapy with ICU and non-ICU Patients

In by Alexa Driscoll

Reduction of Hypoglycemia Across 180 U.S. Hospitals Using eGlycemic Management System® for IV Insulin Therapy with ICU and non-ICU Patients Presentation Diabetes Technology Society (DTS) Virtual Poster Meeting Date June 18, 2020 Authors Joseph Aloi, MD, Raymie McFarland, CCGB OBJECTIVE Evaluate the broad-scale impact of eGlycemic Management System® (eGMS®)* on incidence of hypoglycemia among ICU and non-ICU patients receiving intravenous …

Read More

Improved Patient Safety and Glycemic Outcomes in the ICU Using Computer-Guided Intravenous Insulin Therapy Versus Subcutaneous Insulin Therapy

In by Alexa Driscoll

Improved Patient Safety and Glycemic Outcomes in the ICU Using Computer-Guided Intravenous Insulin Therapy Versus Subcutaneous Insulin Therapy Presentation Diabetes Technology Society (DTS) Virtual Poster Meeting Date June 18, 2020 Authors Marina Rabinovich, PharmD, BCPS, Alexandria Hall, PharmD, Rita Gayed, PharmD, BCCCP, Katleen Chester, PharmD, BCCCP, Jennifer Crowe, MHA, CPHQ, Jordan Messler, MD, SFHM, FACP OBJECTIVE Compare the safety and …

Read More

Use of Technology Reduces Incidence of Hypoglycemia- Related Adverse Drug Events Among Patients Requiring Insulin Therapy While Hospitalized

In by Alexa Driscoll

Use of Technology Reduces Incidence of Hypoglycemia-Related Adverse Drug Events Among Patients Requiring Insulin Therapy While Hospitalized Presentation Diabetes Technology Society (DTS) Virtual Poster Meeting Date June 18, 2020 Authors Debra Dudley, BS, RN, CDE, Mary Gaines, MSN, RN, BC-ADM OBJECTIVE Reduce hypoglycemia-related adverse drug events among patients requiring insulin therapy while hospitalized. METHOD Using insulin to control blood glucose …

Read More

Utilization of Computer-Guided Insulin Dosing Reduces Hypoglycemia Adverse Drug Events, Length of Stay and Hospitalization Costs at a Large Pacific Northwest Health System

In by Alexa Driscoll

Utilization of Computer-Guided Insulin Dosing Reduces Hypoglycemia Adverse Drug Events, Length of Stay and Hospitalization Costs at a Large Pacific Northwest Health System Presentation Diabetes Technology Society (DTS) Virtual Poster Meeting Date June 18, 2020 Authors Jamie Casanova, PharmD, BCPS, Ann Ohlin, ARNP, Dan Yamasaki, MA, MS, MBA OBJECTIVE Determine whether use of the eGlycemic Management System® (eGMS®)*, an EHR-integrated …

Read More

Sustained Hypoglycemia Reduction Using eGlycemic Management System® to Manage Insulin Infusion Therapy Among Critical Care Patients

In by Alexa Driscoll

Sustained Hypoglycemia Reduction Using eGlycemic Management System® to Manage Insulin Infusion Therapy Among Critical Care Patients Presentation Diabetes Technology Society (DTS) Virtual Poster Meeting Date June 18, 2020 Authors Barbara McLean, MN, RN, CCNS-BC, NP-BC, Marina Rabinovich, PharmD, BCPS, Jordan Messler, MD, SFHM, FACP OBJECTIVE Identify whether reductions in hypoglycemia have been sustained among critical care patients receiving insulin infusion …

Read More

Improved Glycemic Control in the Hospital Using Computer-Driven eGylcemic Management System® Plus High-Reliability Strategies for Basal Bolus Subcutaneous Insulin Therapy

In by Alexa Driscoll

Improved Glycemic Control in the Hospital Using Computer-Driven eGlycemic Management System® Plus High-Reliability Strategies for Basal Bolus Subcutaneous Insulin Therapy Presentation Diabetes Technology Society (DTS) Virtual Poster Meeting Date June 18, 2020 Authors H. Courtenay Harrison, Jr., MD, Susan DeAbate, RN, MSN/ED, CDE, Tim Pike, MD, Peggy Braun, RN, BSN, MHA, CENP, Angel Harper-Clarke, BSN, RN, CMSRN, Jordan Messler, MD, …

Read More

June 13, 2020

Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes using Continuous Glucose Monitoring

In by Alexa Driscoll

Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes using Continuous Glucose Monitoring Presentation ADA Virtual 80th Scientific Sessions Date June 13, 2020 Authors Bruce Bode, MD, FACE, John Clarke, RN, CDES PURPOSE An IRB-approved proof-of-concept single-center prospective study to evaluate the safety and efficacy of utilizing Glucommander outpatient insulin dosing software to assist providers …

Read More

March 12, 2020

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control

In by Susan Lawrence

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control Publication Current Diabetes Reports Date November 2019 Authors Jagdeesh Ullal,1 Joseph Aloi2 ABSTRACT Purpose of Review: The goal of this review is to summarize information about insulin dosing software and calculators used as computerized decision support systems or electronic glucose management systems (eGMS). These are used for hospitalized, insulin-treated patients with diabetes. …

Read More

December 10, 2019

Reducing Critical Hypoglycemia Through Quality Improvement Initiatives and Implementation of an eGlycemic Management System

In by Heather DelCarpini

Reducing Critical Hypoglycemia Through Quality Improvement Initiatives and Implementation of an eGlycemic Management System Presentation IHI National For​um on Quality Improvement in Health Care Date December 2019 Authors Debra Dudley,1 Gam Narapanya,2 Michael Yurso,2 Mary Gaines,3 Jennifer Crowe,3 AIM Reduce critical hypoglycemia (blood glucose <40 mg/dL) among hospitalized patients within two years. BACKGROUND On average, one of every three hospitalized …

Read More

Technology-Enabled Glycemic Management Leads to Reductions in Variation and Increased Use of Basal Bolus Regimens for Subcutaneous Insulin Therapy

In by Heather DelCarpini

Technology-Enabled Glycemic Management Leads to Reductions in Variation and Increased Use of Basal Bolus Regimens for Subcutaneous Insulin Therapy Presentation IHI National For​um on Quality Improvement in Health Care Date December 2019 Authors Susan M. De Abate,1 H. Courtenay Harrison, Jr.,1 Jordan Messler,2 AIM Decrease clinical practice variation for glycemic management and increase the number of insulin-requiring patients treated with …

Read More

February 15, 2018

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander

In by Heather DelCarpini

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2018 Authors Bruce Bode, John Clarke, Andrew Rhinehart, Robby Booth BACKGROUND Effective basal bolus insulin therapy requires dose titration to identify the right doses for each individual patient. Self-monitoring of blood glucose …

Read More